About Rejuvenate Bio
Rejuvenate Bio is a company based in San Diego (United States) founded in 2017 by Noah Davidsohn, George Church, and Daniel Oliver.. Rejuvenate Bio has raised $14.58 million across 1 funding round from investors including KdT Ventures, Digitalis Ventures and VCapital. The company has 39 employees as of December 31, 2022. Rejuvenate Bio offers products and services including Gene Therapy Pipeline. Rejuvenate Bio operates in a competitive market with competitors including Beam Therapeutics, eGenesis, Korro Bio, Novogene Corporation and Metagenomi, among others.
- Headquarter San Diego, United States
- Employees 39 as on 31 Dec, 2022
- Founders Noah Davidsohn, George Church, Daniel Oliver
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rejuvenate Bio Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.58 M (USD)
in 1 rounds
-
Latest Funding Round
$14.58 M (USD), Series A
Apr 19, 2021
-
Investors
KdT Ventures
& 4 more
-
Employee Count
39
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rejuvenate Bio
Rejuvenate Bio offers a comprehensive portfolio of products and services, including Gene Therapy Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops treatments for chronic diseases via gene therapy approaches
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Rejuvenate Bio
Rejuvenate Bio has successfully raised a total of $14.58M through 1 strategic funding round. The most recent funding activity was a Series A round of $14.58 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $14.6M
-
First Round
First Round
(19 Apr 2021)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Series A - Rejuvenate Bio | Valuation | KdT Ventures , Digitalis Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rejuvenate Bio
Rejuvenate Bio has secured backing from 5 investors, including venture fund and angel investors. Prominent investors backing the company include KdT Ventures, Digitalis Ventures and VCapital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in frontier science ventures.
|
Founded Year | Domain | Location | |
|
Digitalis Ventures is engaged in health-focused investments.
|
Founded Year | Domain | Location | |
|
Venture capital investment opportunities are provided for accredited investors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rejuvenate Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rejuvenate Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rejuvenate Bio Comparisons
Competitors of Rejuvenate Bio
Rejuvenate Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beam Therapeutics, eGenesis, Korro Bio, Novogene Corporation and Metagenomi, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| domain | founded_year | HQ Location |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Next-generation gene editing tools are developed for drug enhancement.
|
|
| domain | founded_year | HQ Location |
Genetic therapies for diseases are developed using prime editing technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rejuvenate Bio
Frequently Asked Questions about Rejuvenate Bio
When was Rejuvenate Bio founded?
Rejuvenate Bio was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Where is Rejuvenate Bio located?
Rejuvenate Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Rejuvenate Bio?
Daniel Oliver is the current CEO of Rejuvenate Bio. They have also founded this company.
Is Rejuvenate Bio a funded company?
Rejuvenate Bio is a funded company, having raised a total of $14.58M across 1 funding round to date. The company's 1st funding round was a Series A of $14.58M, raised on Apr 19, 2021.
How many employees does Rejuvenate Bio have?
As of Dec 31, 2022, the latest employee count at Rejuvenate Bio is 39.
What does Rejuvenate Bio do?
Rejuvenate Bio was founded in 2017 and is based in San Diego, United States. A gene-editing platform is developed by the company for anti-aging therapies targeting dogs. Technology has been applied to modulate gene activity in aged mice. Plans are in place to modify two genes addressing four aging-related diseases: heart and kidney failure, obesity, and diabetes. Operations focus on biotechnology within the veterinary and longevity sectors.
Who are the top competitors of Rejuvenate Bio?
Rejuvenate Bio's top competitors include eGenesis, Tessera Therapeutics and Novogene Corporation.
What products or services does Rejuvenate Bio offer?
Rejuvenate Bio offers Gene Therapy Pipeline.
Who are Rejuvenate Bio's investors?
Rejuvenate Bio has 5 investors. Key investors include KdT Ventures, Digitalis Ventures, VCapital, Katherine High, and Kendall Capital Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.